Demant A/S Sponsored ADR (WILYY)
OTC
Closed
Aug 21, 2026
Day's Range
23.0052 wk Range
13.45Overview - WILYY - Demant A/S Sponsored ADR
Key Statistics
Valuation
Enterprise Value
4.46B
P/E (Trailing)
‪25.55‬
Price / Sales (TTM)
‪0.39‬
Price / Book
‪5.53‬
EV / EBITDA
‪5.74‬
Profitability
Profit Margin
‪6.55%‬
Operating Margin
‪16.52%‬
Return on Assets
‪7.28%‬
Return on Equity
‪23.29%‬
Ownership
Shares Outstanding
210.89M
Float
167.64M
Price stats
Beta
‪0.75‬
50-Day Avg
‪20.82‬
200-Day Avg
‪17.39‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - WILYY - Demant A/S Sponsored ADR
Peers - WILYY - Demant A/S Sponsored ADR
Peer Comparison
Compared with companies in Medical Devices listed on OTC.
Profile Summary - WILYY - Demant A/S Sponsored ADR
About
Demant A/S Sponsored ADR represents the American Depositary Receipt of Demant A/S, a leading international hearing healthcare company. It provides a broad range of hearing solutions, audiometric equipment, and personal communication. This ADR allows U.S. investors to conveniently participate in Demant's global…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
